Human heart with bronchial tree, illustration

New Mutations Linked to Inherited Heart Condition Uncovered

University of Oxford study uncovers new mutations that increase risk for hypertrophic cardiomyopathy, a common, inherited heart condition, and creates a genetic risk score able to accurately predict cases and prognosis.
CRISPR technology

Mammoth, IDbyDNA Get DARPA Funds for CRISPR Diagnostics Development

DARPA identified five disease categories for which the devices should detect pathogens and biomarkers: respiratory illnesses, febrile illnesses, vector-borne illnesses, gastrointestinal illnesses, and sepsis.
Scientists conducting the process of Polymerase chain reaction (PCR) to amplify DNA by using a thermocycler to create samples

Thermo Fisher to Buy POC Molecular Dx Provider Mesa Biotech

Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A.
The combination of Bristol-Myers Squibb (BMS)'s marketed cancer immunotherapies Opdivo (nivolumab) plus a low dose of Yervoy (ipilimumab) showed durable clinical benefit in a Phase II trial as a first-line treatment in patients with microsatellite instability-high (MSI-H) or DNA mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)

Guardant Throws Hat in Early Cancer Detection Ring with CRC Test

Guardant Reveal, is a plasma-only ctDNA test for detection of early-stage colorectal cancer, with additional cancer types to follow. The minimal residue disease test, which will have a turnaround time of seven days, had been in development since 2016 under the name LUNAR-1, and was launched for research use only in 2019.
cancer cells

Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

In this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.

Rapid PCR-Based Test Developed to Detect Pneumonia in Patients with Severe COVID-19

Normally, confirming a pneumonia diagnosis requires growing bacterial samples from patients in a lab, which is time-consuming. The new test can identify 52 different pathogens, and can be done in around four hours, without needing to grow the bacteria.
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Anticancer treatment Conceptual illustration

New RNA-seq Method Uses Aneuploidy to Distinguish Cancer Cells

Known as CopyKAT (copy number karyotyping of aneuploid tumors), the tool serves as a computational method for detecting cancerous cells amidst large and complex data sets emerging from RNA-sequencing.

Comprehensive Genomic and Immune Profiling to Support Drug Development

In this Clinical OMICs webinar, sponsored by Illumina, we will discover how combining molecular and immune profiling's power to drive molecular-based testing is improving stratification methods and patient outcomes. Additionally, our expert panelist will showcase the impact of a scalable, comprehensive assay, and infrastructure in the context of drug development.
Scroll Up